ARK Invest Genomic Revolution Fund Targets DNA Sequencing and Gene Editing Companies for Long-Term Growth
ARK Invest's Genomic Revolution Fund targets 30-50 DNA sequencing and gene editing companies including CRISPR technology firms, seeking long-term capital growth from healthcare, agriculture, and pharmaceutical innovations since 2014.